Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
Price:
108.58 USD
-1.73%
Market Closed
Updated:
May 17, 2024
Jazz Pharmaceuticals PLC
Operating Expenses
|
Jazz Pharmaceuticals PLC
Operating Expenses Peer Comparison
Comparables:
PRGO
AVDL
G
GHRS
COPN
OVB
Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
|
Operating Expenses
-$2.9B
|
CAGR 3-Years
-24%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
-17%
|
|
|
Perrigo Company PLC
NYSE:PRGO
|
Operating Expenses
-$1.4B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
-6%
|
|
|
Avadel Pharmaceuticals PLC
NASDAQ:AVDL
|
Operating Expenses
-$201.5m
|
CAGR 3-Years
-54%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
-11%
|
|
G
|
GH Research PLC
NASDAQ:GHRS
|
Operating Expenses
-$41.2m
|
CAGR 3-Years
-351%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Cosmo Pharmaceuticals NV
SIX:COPN
|
Operating Expenses
-€45.2m
|
CAGR 3-Years
-14%
|
CAGR 5-Years
6%
|
CAGR 10-Years
-6%
|
|
|
Ovoca Bio PLC
LSE:OVB
|
Operating Expenses
-€2.3m
|
CAGR 3-Years
15%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
12%
|
See Also
What is Jazz Pharmaceuticals PLC's Operating Expenses?
Operating Expenses
-2.9B
USD
-2.9B
USD
Based on the financial report for Mar 31, 2024, Jazz Pharmaceuticals PLC's Operating Expenses amounts to -2.9B USD.
What is Jazz Pharmaceuticals PLC's Operating Expenses growth rate?
Operating Expenses CAGR 10Y
-17%
-17%
Over the last year, the Operating Expenses growth was 9%. The average annual Operating Expenses growth rates for Jazz Pharmaceuticals PLC have been -24% over the past three years , -20% over the past five years , and -17% over the past ten years .
You don't have any saved screeners yet
